Murray Dallan sold SRPT
March 10, 2025 · Form 4 insider transaction
Murray Dallan sold 2,737 shares of Sarepta Therapeutics, Inc. at $100.13 per share, a transaction worth $274.1K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
2,737
Price
$100.13
Total value
$274.1K
InsiderMurray Dallan
RoleOfficer
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateMarch 10, 2025
Filing dateMarch 11, 2025
Shares owned after29,926
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares were sold by the Company to satisfy tax withholding obligations related to vesting of PSUs granted on March 7, 2022.